STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)		1 Months Ended			12 Months Ended
	Nov. 06, 2020	Oct. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Stock based compensation					$ 823,564	$ 1,246,019
Number of common shares issued for services, shares					106,000
Number of common shares issued for services, amount						$ 41,071
Number of options granted					62,674,054	3,600,000
Vesting term					3 years
Vesting rights description					The Company granted Mr. Kumnick and Mr. Broenniman granted options to acquire 33,333,334 and 16,666,666 shares of common stock upon their employment. The options granted to Mr. Kumnick and Mr. Broenniman vest 20% at date of the grant with the balance vesting upon achieving certain performance thresholds.
Common stock, authorized					1,000,000,000	1,000,000,000
Common stock, issued					589,272,023	518,125,454
Common stock, outstanding					589,272,023	518,125,454
Preferred stock, authorized					20,000,000
Number of stock granted					36,821,683	1,251,750
Number of options exercisable					113,185,727
Exercise price of option					$ 0.19
Stock Opton [Member]
Shares issued					1,700,000
Warrant 1 [Member]
Description of warrants			Company entered into and consummated a private transaction pursuant to which a portion of the Company's $0.10 Warrants were exercised for cash at an exercise price of $0.07 per share. In addition, the holders that exercised the $0.10 Warrants received a $0.15 Warrant for every four $0.10 Warrants exercised. As a result, the Company issued 10,008,333 shares of common stock and 2,502,085 $0.15 Warrants in consideration of $700,583.
Warrant 2 [Member]
Description of warrants			Company entered into and consummated a private transaction pursuant to which a portion of the Company's $0.05 Warrants were exercised for cash. In addition, the holders that exercised the $0.05 Warrants received a $0.15 Warrant for every two $0.05 Warrants exercised. As a result, the Company issued 4,632,000 shares of common stock and 2,316,000 $0.15 Warrants, in consideration of $231,600. Separately, certain holders of the $0.05 Warrants to acquire 1,770,000 shares of common stock exercised on a cashless basis resulting in the issuance of 560,659 shares of common stock.
Warrant 3 [Member]
Description of warrants			Company entered into and consummated a private transaction pursuant to which a portion of the Company's $0.06 Warrants were exercised. In addition, the holders that exercised the $0.06 Warrants also received $0.15 Warrant for every two $0.06 Warrants exercised. As a result, the Company issued 5,280,000 shares of common stock and 2,640,000 $0.15 Warrants in consideration of $316,800.
Common Stock [Member]
Number of common stock purchased, shares				1,562,500
Issued of stock					31,500,000
Number of common shares issued for services, amount						$ 41
Common stock, outstanding					589,272,023	518,125,454	478,950,996
Warrant [Member]
Number of common stock purchased, shares					29,400,000
Issued of stock					29,400,000
Shares issued					1,700,000
Warrant term					5 years
Exercise price					$ 0.15
Description of warrants					The Company issued approximately 7.5 million common stock warrants for a term of five years at an average exercise price of $0.15 cents in connection with cash exercises of previously issued warrants. The Company recorded a charge of approximately $367,000 in connection with an inducement to the warrant holders who exercised their outstanding warrants.
Ten Employees And One Non-Employee [Member]
Vesting period, description						The options have a term of ten years with vesting ranging from immediate to a three-year period. All options granted approximated fair value.
Restricted Stock [Member]
Number of stock granted					8,000,000
Employee Stock Option [Member]
Stock based compensation					$ 823,000	$ 3,600,000
Unrecognized compensation costs					$ 801,000
Number of options granted						150,000
Vesting term						10 years
Number of stock vested						125,000
Service Provider [Member]
Number of common shares issued for services, shares					5,000,000
Number of options granted					12,674,000
Number of stock granted					3,000,000
Accredited Investors June 2019 [Member] | Warrant [Member]
Stock based compensation						$ 1,246,000
Unrecognized compensation costs						$ 1,251,750
Warrant term						5 years
Exercise price						$ 0.088
Subscription Agreements [Member] | June 2020 Accredited Investors [Member]
Number of common stock purchased, shares			3,441,558
Number of common shares issued, amount			$ 200,000
Subscription Agreements [Member] | Accredited Investors 2019 [Member] | Two Service Providers [Member]
Number of common shares issued for services, shares				411,000
Number of common shares issued for services, amount				$ 41,000
Subscription Agreements [Member] | Accredited Investors 2019 [Member] | Common Stock [Member]
Number of common stock purchased, shares				38,764,000
Number of common shares issued, amount				$ 3,100,000
Subscription Agreements [Member] | Accredited Investors 2019 [Member] | Warrant [Member]
Number of common stock purchased, shares				1,251,750
Warrant term				5 years
Fair value of warrants				$ 79,000
Cash fee				$ 173,000
Exercise price				$ 0.088
Securities Purchase Agreements [Member]
Description of Securities Purchase	Ipsidy Inc. entered into Securities Purchase Agreements with several accredited investors (the "October 2020 Accredited Investors") pursuant to which the October 2020 Accredited Investors agreed to purchase an aggregate of 52,435,000 shares of the Company's common stock together Warrants to acquire 26,217,500 shares of common stock for a term of five years at an exercise price of $0.15 per share for an aggregate purchase price of approximately $5.24 million. In connection with this private offering, the Company paid a registered broker-dealer, a cash fee of approximately $367,000 and issue the broker-dealer a common stock purchase warrant to acquire approximately 3.15 million shares of common stock of the Company exercisable for a term of five years at an exercise price of $0.15 per share.	Ipsidy Inc. entered into Securities Purchase Agreements with several accredited investors (the "October 2020 Accredited Investors") pursuant to which the October 2020 Accredited Investors agreed to purchase an aggregate of 52,435,000 shares of the Company's common stock together Warrants to acquire 26,217,500 shares of common stock for a term of five years at an exercise price of $0.15 per share for an aggregate purchase price of approximately $5.24 million. In connection with this private offering, the Company paid a registered broker-dealer, a cash fee of approximately $367,000 and issue the broker-dealer a common stock purchase warrant to acquire approximately 3.15 million shares of common stock of the Company exercisable for a term of five years at an exercise price of $0.15 per share.